Marc Carrier/X
Aug 18, 2025, 23:53
Radiotherapy and VTE Risk: Insights from Marc Carrier and Colleagues
Marc Carrier, Professor at Ottawa Hospital Research Institute, recently has shared a post on X:
“Radiotherapy is essential in cancer care, but evidence shows it may independently raise the risk of VTE.
This review in RPTH journal highlights mechanisms, diagnostic challenges, and why tailored thromboprophylaxis, not blanket use, is needed.”
Read the full article here.
Title: Radiotherapy—the not-so-insignificant contributor to cancer-associated venous thrombosis
Authors: Gerard Gurumurthy, Jacob Miller, Marc Carrier, Alok Khorana, Jecko Thachil
Stay informed on all science in Hematology with Hemostasis Today.
-
Aug 26, 2026, 17:39Charan Gubba: Adult ITP – A major shift in the 2026 ASH Guidelines
-
Aug 26, 2026, 17:38Stephan A Mayer: Early Imaging Reveals Higher Risk of Hematoma Expansion After ICH
-
Aug 26, 2026, 17:09Kemal Karaagac: NOACs May Offer Cognitive and Clinical Benefits in AF With Alzheimer’s Disease
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease